To hap or not to hap? | GenomeWeb

To hap or not to hap?

Premium

Language emerged as an overriding theme at the Human Genome Haplotype Map meeting this July in Washington, DC. The meeting, sponsored by NHGRI, brought together about 150 scientists, ethicists, and industry executives to discuss the proposal to create a public haplotype map.

While method and marker density questions were debated, a major point of contention was how many populations and which ones to genotype, with arguments made for multiple- and single-population mapping approaches.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.